Summary
Introduction
Owing to its very low water-solubility unconjugated bilirubin-IXa (Z-configuration) requires conjugation before efficient biliary secretion is attained 11, 21. It has been accepted that biliary secretion of conjugates is the rate-limiting step in overall hepatic transport because the plasma concentration of direct-reacting bilirubin increases when large amounts of unconjugated bilirubin are injected [3, 41. However, in studies of different animal species, a remarkable correlation was found between the hepatic bilirubin UDP-glucuronosyltransferase activity assayed in vitro and the apparent maximal biliary secretion rate (T,,,) [5, 61, suggesting that conjugation of bilirubin might determine the maximal biliary output. The present investigations have therefore been carried out in rats with different transferase activities to observe possible changes in T,,,. At the same time, concentrations of conjugated and unconjugated bilirubin in plasma, liver and bile have been determined. By pharmacologically modifying the transferase levels in heterozygous Gunn rats and their parent Wistar rats, it was W . Van Steenbergen and J. Fevery possible to show that conjugation rather than biliary secretion is the major determinant of the maximal biliary output of bilirubin.
In addition, since decreased biliary output of bilirubin diglucuronide has been documented in humans with bilirubin UDP-glucuronosyltransferase deficiency, such as neonates [7, 81 or patients with Crigler-Najjar disease or Gilbert's syndrome [9, 101, the biliary secretion of monoand di-conjugates was also related to transferase activities.
Methods

Experimental design
Male Wistar-R (JJ) and heterozygous Gunn rats (Jj), weighing 250-350 g, were used. The latter were the first generation of male Wistar-R x female Gunn rats. Under pentobarbitone anaesthesia (6 mg/100 g intraperitoneally) the common bile duct and one jugular vein were cannulated with a polyethylene catheter. Rectal temperature was kept at 37OC by heating the operation table. Rats were then put in restraining cages and transferred to a premature infant incubator to keep the body temperature constant at 37OC. As soon as bile flow was constant, three control bile sample collections each of 5 min duration were made. Unconjugated bilirubin (Merck, Darmstadt, Germany), 3-42 pmo1/100 g body wt., dissolved in NaOH (0.1 mol/l) and brought to pH 8.5 with HCl (0-15 mol/l), was then injected followed by a continuous infusion of 0.26 pmol min-' 100 g-' body wt. to obtain the T,,, [3J. Bile was further collected on ice in the dark in preweighed tubes for 65 min as follows: three samples of 5 rnin, two of 10 min and two of 15 min. After weighing the tubes, all samples were stored at -2OOC. After 65 min the rats were killed by cervical dislocation and exsanguination. Blood was sampled on dry heparin; the liver was flushed with ice-cold NaCl solution (1 54 mmol/ 1 :saline) injected via the hepatic veins and stored at -2OOC for further analysis.
Changes in glucuronosyltransferase activities in vivo
Different glucuronosyltransferase activities were obtained by using heterozygous Gunn rats (low enzyme activity) and Wistar rats, in control conditions and after treatment for 2 weeks with intraperitoneal sodium phenobarbitone (35 -4 pnol day-' 100 g-') dissolved in saline, or with glutethimide (18.4 or 34-6 m o l day-' 100 g-') dissolved in polyethylene glycol 400.
Materials and procedures
Glutethimide was a gift from Ciba-Geigy, Basel, Switzerland.
Bile flow was measured by weighing the tubes before and after bile collection. Total bilirubin in liver, serum and bile was determined after diazo-cleavage with p-iodoaniline [ (Table 1) . However, when they were allowed to recover for 3 h from anaesthesia, Jj rats excreted less (30 f 2%, n = 3) of the bilirubin conjugates as diglucuronide in bile than did Wistar rats (48 1%, n = 3). Basal bile flow and bilirubin concentration were comparable in both groups.
After the administration of bilirubin, a rapid increase in biliary bilirubin was observed, reaching a constant and maximal output (T,) from 15 min on in Wistar rats but less rapidly in Jj rats (Fig. 1 ). Bile flow in T, conditions did not differ from basal values. The bilirubin concentration reached in bile of Jj rats was approximately 66% of that of Wistar rats, and the T,,, was 84% (Table 1) . A comparable maximal excretory rate of 70-8 nmol min-' 100 g-' could be obtained for 10 min in Jj rats with a single bolus injection of 8.55 pno1/100 g body wt.; this was not investigated in Wistar rats. Bilirubin diconjugates in T, bile were significantly lower in Jj rats than in Wistar rats (Table l), whereas the hepatic and plasma bilirubin content (total as well as conjugated) at the end of the experiment was higher in the Jj rats ( Table 1) Biliary bilirubin concn.
Bilirubin T, (nmol mh-' 100 g-l)
83.6 L 3. pmol of bilirubin was infused per 100 g body wt.; 24% of this amount was recovered in bile in the Wistar rats and 20% in the Jj rats (see Table 3 ).
Effects of pretreatment with phenobarbitone and glutethimide
Both agents enhanced bilirubin UDPglucuronosyltransferase activity (GTA); this effect was more pronounced in Wistar rats (about 2-6-fold) than in GTA-deficient Jj rats (about 1.3-fold) ( Table 2 ). As expected, phenobarbitone augmented bile flow, whereas a slight increase in flow due to glutethimide was found in Jj rats only under basal conditions. Pigment concentrations in bile were increased in T, samples by pretreatment with both agents in the heterozygous Gunn rats but only by glutethimide in Wistar rats; the pronounced enhancement of bile flow resulting from phenobarbitone produced a dilution effect in the latter group.
After glutethimide or phenobarbitone bilirubin T , increased 1.3-to 1.7-fold in Jj rats and 1.7-to 2-1-fold in JJ rats, whereas the bilirubin excretion reached its highest level earlier (Fig. l) , suggesting that overall hepatic handling of the injected bilirubin was more efficient. As a consequence more bilirubin was found in bile and less in liver and plasma (Table 3) . Pretreatment with glutethimide (18.4 pmo1/100 g) produced effects on all the variables measured similar to those of the twofold higher dosage routinely used.
To make sure that the injected amount of bilirubin was still saturating hepatic metabolism and transport in rats with enhanced glucuronosyltransferase, a twofold amount of bilirubin was given, but T , values were not higher. In phenobarbitone-pretreated rats this higher load produced a decrease in bile flow (Table 4) . As reported for bromosulphophthalein, indocyanine green, taurocholate and other organic anions 115-171 high amounts of bilirubin thus seemed also to exert a cholestatic effect.
Relationship of maximal bilirubin secretion with glucuronosyltransferase activity
As shown in Fig. 2 , a clear relationship between transferase activity and maximal biliary excretion was evident. In heterozygous Gunn rats, the slope was much steeper than in Wistar rats (0.75 versus 0.26), suggesting that a small increase of enzyme activity had a greater effect on T, at low transferase activities. In untreated animals the total conjugating activity in the liver measured in vitro was only slightly higher than the biliary output of bilirubin conjugates in vivo.
Biliary excretion of mono-and di-glucuronides
In acute experiments with anaesthetized animals, bile composition of heterozygous Gunn rats in basal conditions was not different from that of Wistar rats (Table 2) . However, when loaded with bilirubin, Wistar rats were able to maintain an identical percentage of diconjugates, whereas it dropped from 38 f 3% to 19 & 2% in the heterozygous Gunn rat. Stimulation of GTA by phenobarbitone increased the percentage of diglucuronides in both strains of rats. Although glutethimide stimulated the transferase activity to the same extent, no significant changes in the relative proportion of mono-and di-glucuronides occurred.
Bilirubin in serum and liver
By the end of the experiments high amounts of bilirubin were present in liver and serum. Levels were slightly although not significantly higher in the Jj rats; they were decreased by phenobarbitone and to a lesser extent by glutethimide ( Table 2) . Despite the differences in total bilirubin, the ratio of so-called 'conjugated bilirubin' (as measured by using diazotized anthranilate at pH 2.7) to total bilirubin was equal in the livers of Wistar and Jj rats, representing an equilibrium state of about 0.14:l. This suggested that a certain amount of conjugate is built up ('packed') before biliary secretion. Pretreatment with phenobarbitone in Wistar but not in Jj rats decreased this ratio; this might be related to the choleretic effect of this drug.
No changes of this ratio in plasma was induced by phenobarbitone or glutethiiide but a greater percentage of 'conjugates' was present in Jj than in Wistar rat plasma (21% versus 4% respectively). Although conjugation is deficient in Jj rats, a more pronounced reflux of conjugates to plasma seemed to exist. This might be related to a lower secretory efficiency for monoglucuronides, as Jj rats produced mainly monoconjugates.
Discussion
It has generally been accepted that biliary secretion is the rate-limiting step in bilirubin metabolism at high bilirubin loads; the apparent excretory maximum (T,) would thus mainly represent the maximal biliary secretory capacity. However, the present work showed that an increase of the conjugation capacity is paralleled by an increased biliary output both in Wistar and in glucuronosyltransferase-deficient heterozygous Gunn rats, suggesting that conjugation is It was presumably too low to obtain a real saturation (T,) of the conjugation capacity in animals pretreated with phenobarbitone. As not enough bilirubin is available, increasing the conjunction rate is not paralleled by a greater biliary output. Indeed, as indicated in Fig. 1 , when only 36% of the classical amount of bilirubin was administered, a lower biliary output was obtained.
Bilirubin diglucuronide in bile is decreased in glucuronosyltransferase-deficient man and neonates [7-10, 221; similarly heterozygous Gunn rats excreted less diglucuronide than Wistar rats when loaded with bilirubin (T, bile). Furthermore, when the glucuronosyltransferase activity was increased with phenobarbitone (the present work), clofibrate [ 191 or spironolactone [231 the relative proportion of diconjugates in bile increased both in Jj and Wistar rats. This relationship between hepatic GTA and amount of diglucuronide in bile did not hold for rats pretreated with glutethimide, as the enzyme activity increased without changes in the ratio mono-to di-conjugates. It is not clear if this is related to the fact that both phenobarbital [241 and clofibrate (although to a lesser extent) 119, 201 increase the bile flow in addition to the transferase activity. There is still some controversy concerning the mechanism of diglucuronide formation [25-291 and many hypotheses can be advanced. The increased bile flow could, for example, be important in promoting the efflux of intrahepatic diglucuronide, which in turn might stimulate diglucuronide formation from monoglucuronide. A high load of bilirubin produced a decrease in the proportion of bilirubin diglucuronide excreted in bile by transferasedeficient Jj rats. Pretreatment with phenobarbitone could partially overcome this. The excretion of diglucuronide is thus mainly but not solely dependent on the glucuronosyltransferase activity.
Depending on the strain and whether or not enzyme-induced animals are investigated, 20-50% of the bilirubin administered over the 65 min period was excreted in bile, and 0-3-3.7% was present as conjugated bilirubin in plasma and 0-2-2.0% in the liver (Table 3) . Comparable figures have been reported for SpragueDawley rats 121, 301, for the adult guinea pig (30%) 1311 and the adult rhesus monkey (2743%) [321, the two last-named species receiving only half of the dosage given in the present study. The fact that only small amounts of conjugates can be detected in liver and plasma (and the ethyl anthranilate method used might even slightly overestimate conjugates in these samples) also suggests that the biliary secretion rate is very effective for conjugates and thus not really rate-limiting. This small increase of conjugates in plasma was used previously as a proof that biliary secretion was rate-limiting, but Snyder et al. [331 showed that the plasma levels of direct-reacting bilirubin rose proportionally with the concentration in bile, suggesting an equilibrium state rather than limitation. Final proof that conjugation is ratelimiting will require studies with purified bilirubin conjugates.
